Original research
par
Evans, Elizabeth A. et al
Date de publication
2022
Géographie
USA
Langue de la ressource
English
Texte disponible en version intégrale
Non
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
Studied outcomes of buprenorphine treatment delivered in jail settings
Constatations/points à retenir
Among incarcerated adults with opioid use disorder, risk of recidivism after jail exit is lower among those who were offered buprenorphine during incarceration. Findings support the growing movement in jails nationwide to offer buprenorphine and other agonist medications for opioid use disorder.
La conception ou méthodologie de recherche
We examined outcomes of all incarcerated adults with opioid use disorder (n = 469) who did (FCSO n = 197) and did not (HCHC n = 272) have the opportunity to receive buprenorphine.
Mots clés
Mortality
Harm reduction
Crime
Legal system/law enforcement
Substitution/OAT
